{
    "documentMetadata": {
        "title": "Burns, Infected Wound",
        "sourceFile": "Burns, Infected Wound.pdf",
        "lastUpdated": "2024-11-01"
    },
    "content": [
        {
            "type": "header",
            "level": 1,
            "text": "Clinical Setting"
        },
        {
            "type": "list",
            "items": [
                "Infected burn wounds. Proposed standardized definition: J Burn Care Res 28:776, 2007.",
                "For surgical debridement of infected necrotic tissue, application of skin grafts and/or skin substitutes, and /or topical medications. See JAMA 283:716, 2000; Clin Plastic Surg 36: 597, 2009.",
                "Critically ill patient with suspected burn wound sepsis.",
                "Ideal care is in dedicated burn unit.",
                "Time line for likely pathogens (Clin Infect Dis 2017;65:2130)."
            ]
        },
        {
            "type": "header",
            "level": 1,
            "text": "Etiologies"
        },
        {
            "type": "list",
            "items": [
                "Streptococcus pyogenes",
                "Enterobacter sp.",
                "Staphylococcus aureus",
                "Staphylococcus epidermidis",
                "Enterococcus faecalis",
                "Escherichia coli",
                "Pseudomonas aeruginosa",
                "Fungi (rare) (Clin.Infect.Dis. 2024; 79:682)",
                "Herpes virus (rare)."
            ]
        },
        {
            "type": "header",
            "level": 1,
            "text": "Primary Regimens"
        },
        {
            "type": "list",
            "items": [
                "Quantitative wound cultures, blood cultures, and then empiric antimicrobial therapy",
                "Vancomycin 15-20 mg/kg IV q8-12h to achieve preferred target AUC24 400-600 \u00b5g/mL x hr (see vancomycin AUC dosing calculator); alternative is trough of 15-20 \u00b5g/mL + (Meropenem 1 gm IV q8h or Cefepime 2 gm IV q8h) + Fluconazole 400 mg IV once daily, if Candida infection suspected",
                "Adjust any empirical regimen based on culture results."
            ]
        },
        {
            "type": "header",
            "level": 1,
            "text": "Alternative Regimens"
        },
        {
            "type": "list",
            "items": [
                "If allergic or intolerant to Vancomycin, could use Daptomycin, 6-12 mg/kg IV once daily",
                "if IgE mediated allergy to beta-lactams, could use Aztreonam 2 gm IV q6h",
                "If ESBL or carbapenemase producing MDR gram-negative bacillus:",
                "See Highly-resistant Gram-negative Bacilli for details"
            ]
        },
        {
            "type": "header",
            "level": 1,
            "text": "Comments"
        },
        {
            "type": "list",
            "items": [
                "Other complications of concern in critically ill burn patient: S. aureus toxic shock syndrome (TSS), suppurative phlebitis, pneumonia.",
                "Review: Initial burn management. N Engl J Med.20191, 380:2349"
            ]
        }
    ]
}